Literature DB >> 3435569

Detection of anticentromere antibodies using cloned autoantigen CENP-B.

N Rothfield1, D Whitaker, B Bordwell, E Weiner, J L Senecal, W Earnshaw.   

Abstract

A solid-phase enzyme-linked immunosorbent assay has been established using a cloned fusion protein, CtermCENP-B [beta-gal], as antigen. The fusion protein carries the major epitope of CENP-B, the major centromeric autoantigen. The enzyme-linked immunosorbent assay was more sensitive than immunofluorescence techniques in detecting anticentromere antibodies in patients with scleroderma or Raynaud's disease, and was weakly positive in 3% of normal controls and in 3% of 70 patients with other connective tissue diseases.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3435569     DOI: 10.1002/art.1780301214

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  18 in total

Review 1.  Anti-centromere antibodies (ACA).

Authors:  C G Kallenberg
Journal:  Clin Rheumatol       Date:  1990-03       Impact factor: 2.980

2.  Use of recombinant RNP peptides 70K and A in an ELISA for measurement of antibodies in mixed connective tissue disease: a longitudinal follow up of 18 patients.

Authors:  D J de Rooij; W J Habets; L B van de Putte; M H Hoet; A L Verbeek; W J van Venrooij
Journal:  Ann Rheum Dis       Date:  1990-06       Impact factor: 19.103

Review 3.  Biomarkers in the management of scleroderma: an update.

Authors:  Giuseppina Abignano; Maya Buch; Paul Emery; Francesco Del Galdo
Journal:  Curr Rheumatol Rep       Date:  2011-02       Impact factor: 4.592

Review 4.  Connective tissue disease in patients presenting with Raynaud's phenomenon alone.

Authors:  C G Kallenberg
Journal:  Ann Rheum Dis       Date:  1991-10       Impact factor: 19.103

5.  The value of synthetic linear epitope analogues of La/SSB for the detection of autoantibodies to La/SSB; specificity, sensitivity and comparison of methods.

Authors:  E E Yiannaki; A G Tzioufas; M Bachmann; J Hantoumi; V Tsikaris; M Sakarellos-Daitsiotis; C Sakarellos; H M Moutsopoulos
Journal:  Clin Exp Immunol       Date:  1998-04       Impact factor: 4.330

6.  Anti-Scl-70 antibodies detected by immunoblotting in progressive systemic sclerosis: specificity and clinical correlations.

Authors:  A Aeschlimann; O Meyer; P Bourgeois; T Haim; N Belmatoug; E Palazzo; M F Kahn
Journal:  Ann Rheum Dis       Date:  1989-12       Impact factor: 19.103

7.  Fine specificity mapping of autoantigens targeted by anti-centromere autoantibodies.

Authors:  Yasmin Akbarali; Jennifer Matousek-Ronck; Laura Hunt; Leslie Staudt; Morris Reichlin; Joel M Guthridge; Judith A James
Journal:  J Autoimmun       Date:  2007-01-08       Impact factor: 7.094

8.  Detection of autoantibodies to ribosomal P protein using recombinant autoantigen in a quantitative immunoassay.

Authors:  T P Gordon; S A Jovanovich; P Sykes; J Bradley; P J Roberts-Thomson
Journal:  Rheumatol Int       Date:  1990       Impact factor: 2.631

Review 9.  Antitopoisomerase and anticentromere antibodies in the sclerodermatosus complex.

Authors:  C G Kallenberg
Journal:  Clin Rev Allergy       Date:  1994

Review 10.  Autoantibodies in systemic sclerosis (scleroderma): clues for clinical evaluation, prognosis and pathogenesis.

Authors:  Alfred Grassegger; Gabriela Pohla-Gubo; Margret Frauscher; Helmut Hintner
Journal:  Wien Med Wochenschr       Date:  2008
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.